Hemo-metabolic impairment in patients with ST-segment elevation myocardial infarction: Data from the INTERSTELLAR registry

CONCLUSIONS: Hemo-metabolic impairment is significantly associated with increased risk of in-hospital and 1-year mortality in patients with STEMI. It remains a significant prognostic factor, regardless of DTB time.PMID:37964646 | DOI:10.5603/cj.93926
Source: Cardiology Journal - Category: Cardiology Authors: Source Type: research